BIO is expanding its work to defend IP
When a biotech firm sells investors on the promise of a new drug, what they are really selling is the intellectual property behind their […]
BIO is expanding its work to defend IP Read More »
National Security
BIO expert: Future of biotech depends on competing with China, updating FDA
Ensuring a brighter future for U.S. biotech requires modernizing the Food and Drug Administration (FDA) and addressing challenges from China, according to Kelly Seagraves,
BIO expert: Future of biotech depends on competing with China, updating FDA Read More »
BIO CEO hails congressional report on threat of China dominating biotech
A year after a congressional commission urged strategic action to prevent China from replacing America as the world leader in biotechnology, we still have
BIO CEO hails congressional report on threat of China dominating biotech Read More »
BIO Board member advises Congress on China’s clinical trial competition
China gains a huge advantage in biotech competition by speeding up clinical trials, and America must respond, a member of the Board of the
BIO Board member advises Congress on China’s clinical trial competition Read More »
Biotech and national security: ‘Time to act but no time to wait’
The threat to America’s leadership in biotech is a threat to our national security that we need to address now, two members of a
Biotech and national security: ‘Time to act but no time to wait’ Read More »
BIO 2025: A few highlights from Day 1
Day 1 of BIO 2025 was all about collaboration: how industry can collaborate with the U.S. government to advance biodefense, how collaboration is key
BIO 2025: A few highlights from Day 1 Read More »
BIO 2025: A strong biodefense requires government-industry partnerships
Biotech’s contribution to America’s biodefense can only be supported through public-private partnerships, but the public sector must provide adequate support and private actors need
BIO 2025: A strong biodefense requires government-industry partnerships Read More »
BIO hosts fly-in focused on biodefense, calls for PAHPA reauthorization
Over 30 representatives from biodefense companies joined the Biotechnology Innovation Organization (BIO) on Capitol Hill in November to meet with bipartisan congressional leaders to
BIO hosts fly-in focused on biodefense, calls for PAHPA reauthorization Read More »
Exclusive: Sen. Todd Young on biosecurity, National Security Commission on Emerging Biotechnology (NSCEB)
Sen. Todd Young (R-IN) was recently named Chair of the National Security Commission on Emerging Biotechnology (NSCEB), established by Congress to recommend policy on biotech and national security.
I am BIO Podcast: Biotechnology is national security technology
American leadership in biotechnology is a vital national security asset in need of protection now, and its importance can be expected to grow in
I am BIO Podcast: Biotechnology is national security technology Read More »